| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 969.99B | 990.59B | 973.04B | 1.07T | 1.01T |
| Gross Profit | 743.00B | 753.19B | 713.36B | 744.16B | 738.16B |
| EBITDA | 89.18B | 82.84B | 114.10B | 127.23B | 179.87B |
| Net Income | -40.68B | -10.81B | 21.75B | 34.20B | 46.91B |
Balance Sheet | |||||
| Total Assets | 1.27T | 1.33T | 1.26T | 1.31T | 1.18T |
| Cash, Cash Equivalents and Short-Term Investments | 91.84B | 98.48B | 126.64B | 137.53B | 156.50B |
| Total Debt | 414.50B | 363.16B | 280.98B | 297.19B | 305.84B |
| Total Liabilities | 645.98B | 677.21B | 615.11B | 681.91B | 611.93B |
| Stockholders Equity | 600.76B | 632.47B | 618.75B | 604.26B | 540.70B |
Cash Flow | |||||
| Free Cash Flow | 65.46B | 23.54B | 33.35B | -19.47B | 30.43B |
| Operating Cash Flow | 109.89B | 48.40B | 89.03B | 46.73B | 122.89B |
| Investing Cash Flow | -43.42B | -83.74B | -35.54B | -41.31B | 63.74B |
| Financing Cash Flow | -77.25B | 23.36B | -75.64B | -52.42B | -176.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥498.97B | 18.43 | 9.77% | 1.73% | 2.18% | 60.81% | |
71 Outperform | ¥566.93B | 16.01 | 13.22% | 1.53% | 18.35% | 31.87% | |
70 Outperform | ¥3.02T | 25.64 | 11.70% | 2.41% | 4.62% | 47.68% | |
69 Neutral | ¥355.71B | 23.54 | 2.72% | 2.61% | 1.37% | -5.60% | |
69 Neutral | ¥304.85B | 32.19 | 6.05% | 3.92% | -1.16% | 36.30% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥1.32T | -32.41 | ― | 2.11% | -1.20% | -2896.72% |
Shiseido has disclosed that it received a surplus dividend of ¥50,358 million from its consolidated subsidiary Shiseido Europe S.A. on September 1, 2025. The payout was recorded as non-operating income in the parent company’s non-consolidated results for the fiscal year ended December 31, 2025, but it does not affect the group’s consolidated earnings, signaling an internal capital move rather than a change in overall group profitability.
For investors, the transaction highlights ongoing cash repatriation from Shiseido’s European operations to the parent company in Japan. While neutral at the consolidated level, the sizable dividend could influence non-consolidated financial metrics, capital allocation flexibility, and perceptions of the earnings strength and cash generation of Shiseido’s European business.
The most recent analyst rating on (JP:4911) stock is a Hold with a Yen2697.00 price target. To see the full list of analyst forecasts on Shiseido Company,Limited stock, see the JP:4911 Stock Forecast page.
Shiseido Company, Limited has recognized an extraordinary loss of ¥180.3 billion in its non-consolidated financial results for fiscal 2025, stemming from a valuation decline in the equity shares of its U.S.-based subsidiary, Shiseido Americas Corp., under Japanese GAAP accounting for financial instruments. This write-down reflects a lower net asset value for the subsidiary but is confined to the parent-only accounts and does not affect Shiseido’s consolidated financial statements for 2025 or its future earnings outlook, limiting direct impact on group-level performance and stakeholders at the consolidated level.
The most recent analyst rating on (JP:4911) stock is a Hold with a Yen2697.00 price target. To see the full list of analyst forecasts on Shiseido Company,Limited stock, see the JP:4911 Stock Forecast page.
Shiseido reported that its full-year 2025 consolidated results modestly exceeded its earlier forecasts, with net sales lifted slightly by favorable foreign exchange effects from a weaker yen and core operating profit beating expectations due to additional benefits from structural reforms and disciplined cost control. Despite weakness in its Americas business and like-for-like sales remaining below targets, operating profit and profit attributable to owners of the parent surpassed projections, supported by smaller-than-expected non-recurring losses and foreign exchange gains, while the company maintained its planned annual dividend of ¥40 per share, signaling stability for shareholders.
The better-than-forecast profitability underscores the effectiveness of Shiseido’s ongoing restructuring and expense management efforts amid a challenging demand environment, especially in the Americas. By keeping its dividend unchanged, the company is balancing a still-declining like-for-like top line with improved earnings quality, suggesting a focus on shareholder returns and financial resilience despite operating headwinds and currency-driven volatility.
The most recent analyst rating on (JP:4911) stock is a Hold with a Yen2697.00 price target. To see the full list of analyst forecasts on Shiseido Company,Limited stock, see the JP:4911 Stock Forecast page.
Shiseido reported full-year 2025 consolidated sales of ¥969.9 billion, down 2.1% year on year, while core operating profit rose 22.4% to ¥44.5 billion as the company benefited from underlying operational improvements. Despite this, non-recurring items drove an operating loss of ¥28.8 billion and a net loss attributable to owners of the parent of ¥40.7 billion, widening from the prior year and weighing on equity per share.
Cash flow from operating activities more than doubled to ¥109.9 billion, supported by stronger core profitability and working capital management, while the company continued to invest and reduced cash and cash equivalents to ¥91.8 billion. Shiseido kept its annual dividend for 2025 at ¥40 per share and plans to raise it to ¥60 in 2026, signaling confidence alongside guidance for 2026 that targets a 2.1% sales increase to ¥990 billion and a return to profitability with ¥42 billion in net income and basic earnings per share of ¥105.12.
The forecasted jump in core operating profit to ¥69 billion and operating profit of ¥59 billion in 2026 suggests that restructuring and cost measures are expected to translate into a stronger earnings base. For investors, the combination of enhanced dividends, improved operating cash flows, and a clear profit recovery target indicates management’s intent to restore shareholder returns and reinforce Shiseido’s competitive position in the global beauty market.
The most recent analyst rating on (JP:4911) stock is a Hold with a Yen2697.00 price target. To see the full list of analyst forecasts on Shiseido Company,Limited stock, see the JP:4911 Stock Forecast page.
Shiseido has completed its voluntary early retirement initiative, the “Next Career Support Plan,” targeting employees of the parent company and selected domestic subsidiaries who met specified age and tenure criteria. While the program initially anticipated about 200 participants, 257 employees ultimately applied and will retire on March 31, 2026, receiving enhanced retirement benefits and optional career transition support. The company expects to book approximately 3 billion yen in non-recurring costs for these special benefits and related expenses in the fourth quarter of fiscal 2025, costs that have already been incorporated into its full-year earnings forecast, suggesting limited incremental impact on reported guidance while supporting ongoing structural reforms and workforce optimization.
The most recent analyst rating on (JP:4911) stock is a Hold with a Yen2190.00 price target. To see the full list of analyst forecasts on Shiseido Company,Limited stock, see the JP:4911 Stock Forecast page.